Dermatology

  • CORRECTION: Laser resurfacing can effectively minimize post surgery scars

    on February 24th, 2017
    In an article titled “Laser resurfacing can effectively minimize post surgery scars,” published Feb. 17, 2017, the type of pigmentation disorder that the patient developed after a kayaking trip during the postoperative period was mischaracterized. The patient developed postinflammatory hyperpigm[...]
  • Vitiligo linked to moles, tanning ability, blistering sunburn

    on February 23rd, 2017
    FROM THE JOURNAL OF INVESTIGATIVE DERMATOLOGY Upper extremity moles were associated with a 37% increase in the likelihood of vitiligo among white women, according to an analysis of the prospective Nurses’ Health Study. “Women with a higher tanning ability and women who had a history of blisterin[...]
  • Tips for taming atopic dermatitis and managing expectations

    on February 23rd, 2017
    AT ODAC 2017 MIAMI (FRONTLINE MEDICAL NEWS) – Tactics for managing patients with atopic dermatitis can go a long way to educate patients, set realistic expectations, and devise strategies for existing therapies, even as clinicians await some promising agents expected on the market soon. “The goo[...]
  • When the iPad is on the other foot

    on February 23rd, 2017
    Sometimes patients take a few notes when I talk, but Niles was different. As I started to spout words of wisdom about his granuloma annulare, he whipped out a tablet and started to type. “How do you spell that again?” he wanted to know. I spelled it out, and Niles tapped away. I launched into [&[...]
  • Lanadelumab reduced hereditary angioedema attacks by 88%-100%

    on February 22nd, 2017
    FROM THE NEW ENGLAND JOURNAL OF MEDICINE Lanadelumab, a monoclonal antibody that inhibits kallikrein, reduced attacks of hereditary angioedema with C1 inhibitor deficiency by 88%-100% in a small, phase I trial. Hereditary angioedema with C1 inhibitor deficiency is a rare disorder characterized by un[...]
  • Comparison of immunosuppressants for early diffuse systemic sclerosis yields mixed results

    on February 22nd, 2017
    FROM ANNALS OF THE RHEUMATIC DISEASES Placing patients who have early diffuse cutaneous systemic sclerosis (dcSSc ) on an immunosuppressant regimen can have a beneficial, but not necessarily sustainable, impact, according to findings from the European Scleroderma Observational Study. “At present, [...]
  • Laser resurfacing can effectively minimize post surgery scars

    on February 17th, 2017
    EXPERT ANALYSIS FROM THE ODAC CONFERENCE MIAMI (FRONTLINE MEDICAL NEWS) – In his practice, Joel L. Cohen, MD, spends a good part of his day doing Mohs surgery, “with the goal of cancer removal, and after surgery, having the patient look good,” he said at the Orlando Dermatology Aesthetic and C[...]
  • Brodalumab approved for psoriasis with REMS required

    on February 16th, 2017
    The Food and Drug Administration has approved brodalumab, an interleukin-17 receptor A-antagonist, for treating adults with moderate to severe plaque psoriasis, with a Risk Evaluation and Mitigation Strategy (REMS) that addresses the “observed risk of suicidal ideation and behavior” in clinical [...]
  • Daptomycin safe, effective for pediatric cSSSI treatment

    on February 15th, 2017
    FROM PEDIATRICS Daptomycin was safe and effective at treating complicated skin and skin structure infections (cSSSI) in children aged 1-17 years, according to Dr. John Bradley of the University of California, San Diego, and his associates. A total of 389 cSSSI patients were included in the study, wi[...]
  • Artificial intelligence, CNN, and diagnosing melanomas

    on February 14th, 2017
    I have a breakthrough article to share with you. It’s about a technology that detects skin cancer. Before I tell you about that, however, I need to teach you a few things. For example, do you know what AI is? How about machine learning? What about CNN? (This column is a nonpolitical arena, so, no,[...]
  • Cost equilibrium in Canada: Inpatient and outpatient treatment of herpes zoster

    on February 14th, 2017
    FROM BMC INFECTIOUS DISEASES Rates of herpes zoster infections have increased substantially since the late 1990s in Canada. This, combined with rising per-episode medical costs and constant per-episode drug costs has led to increased total outpatient costs. But this has been offset by a dramatic dro[...]
  • Why can’t my patient have that miracle drug?

    on February 14th, 2017
    Modern medicine is truly blessed. Dermatology is no exception. With the development of more precise medications, our patients with severe psoriasis and atopic dermatitis no longer have to suffer in misery and social isolation. There is new hope for patients with metastatic melanoma. I recently watch[...]
  • New AJCC guidance brings melanoma staging changes

    on February 13th, 2017
    EXPERT ANALYSIS FROM THE SDEF HAWAII DERMATOLOGY SEMINAR WAILEA, HAWAII (FRONTLINE MEDICAL NEWS) – The Eighth Edition of the American Joint Committee on Cancer Staging Manual includes significant changes in how melanoma is classified. The manual has already been published and is available for purc[...]
Back to top